widespread
diffus
mortal
sever
acut
respiratori
syndrom
sar
caus
new
coronaviru
sarscov
threaten
entir
world
urg
scientif
commun
develop
molecular
serolog
test
assist
rapid
detect
sar
case
implement
control
measur
effect
prophylaxi
antivir
therapi
urgent
need
event
reemerg
highli
contagi
often
fatal
sar
infect
like
known
coronavirus
sarscov
envelop
viru
contain
four
structur
protein
name
membran
envelop
e
spike
nucleocapsid
n
protein
n
protein
amino
acid
predict
phosphoprotein
kda
share
littl
homolog
member
coronaviru
genu
sever
studi
found
n
protein
highli
immunogen
thu
antibodi
respons
patient
sar
direct
frequent
predominantli
nucleocapsid
also
found
anti
n
antibodi
detect
earli
high
specif
infect
therefor
gener
nspecif
reagent
particular
monoclon
antibodi
mab
could
assist
studi
viral
replic
antivir
activ
well
diagnosi
sarscov
infect
variou
diseas
stage
also
found
sar
patient
show
clinic
improv
treat
serum
previous
infect
patient
suggest
passiv
immunotherapi
could
develop
treatment
infecti
diseas
howev
tradit
approach
gener
mab
sarscov
present
difficulti
sever
reason
includ
safeti
concern
handl
sar
particl
overcom
limit
appli
effect
safe
vitro
procedur
base
human
scfv
select
larg
synthet
phage
antibodi
librari
report
identif
product
epitop
character
human
scfv
antibodi
specif
recogn
distinct
n
protein
domain
recombin
mab
found
bind
select
good
affin
distinct
n
protein
epitop
suitabl
specif
identifi
sar
particl
vero
infect
cell
nucleocapsid
n
protein
sarscov
residu
fragment
residu
residu
residu
express
e
coli
dna
recombin
technolog
report
carattoli
di
bonito
et
al
polypeptid
prove
react
specif
sera
sarscov
infect
patient
synthet
human
recombin
antibodi
librari
consist
larg
array
antibodi
combin
scfv
polypeptid
display
surfac
phage
built
random
mutagenesi
three
antibodi
germlin
gene
segment
heavi
chain
light
chain
divers
heavi
chain
creat
random
four
six
posit
replac
preexist
posit
divers
light
chain
creat
random
six
posit
aliquot
librari
contain
cfu
phage
use
isol
specif
human
antibodi
scfv
format
sarscov
n
protein
immunotub
nunc
maxisorp
denmark
coat
overnight
room
temperatur
rt
recombin
purifi
sarscov
n
protein
pb
pan
phage
elut
ml
mm
triethylamin
solut
immedi
neutral
ad
ml
trishcl
ph
elut
phage
use
infect
log
phase
e
coli
bacteria
amplifi
next
round
select
briefli
ml
yt
ampicillin
yta
medium
glucos
inocul
enough
bacteri
suspens
yield
cultur
grown
nm
infect
helper
phage
ratio
around
phagebacteria
rescu
phage
concentr
precipit
peg
use
next
round
pan
usual
three
recov
antigenspecif
antibodi
phage
librari
solubl
scfv
prepar
individu
coloni
grown
flat
bottom
well
nunc
hour
yta
medium
glucos
well
plate
induct
yta
medium
mm
iptg
follow
day
plate
spin
g
minut
supernat
contain
solubl
scfv
recov
test
specif
well
elisapl
nunc
maxisorp
coat
rt
antigen
n
protein
fragment
pb
follow
day
block
solut
consist
non
fat
dri
milk
pb
mpb
ad
plate
wash
pb
contain
tween
tpb
incub
hour
rt
supernat
contain
solubl
scfv
antibodi
antiflag
antibodi
sigmaaldrich
mo
usa
antimous
hrp
conjug
antibodi
dako
denmark
reaction
develop
use
bm
blue
podsubstr
solubl
roch
diagnost
usa
stop
ad
sulfidr
acid
reaction
detect
elisa
reader
biorad
ca
usa
result
express
absorb
nm
nm
sarscov
n
protein
load
onto
sdspage
transfer
nitrocellulos
membran
use
standard
procedur
membran
block
mpb
rt
blot
protein
incub
hour
supernat
contain
solubl
scfv
wash
tpb
incub
antiflag
mous
antibodi
sigmaaldrich
mpb
addit
incub
hour
rt
presenc
goat
antimous
antibodi
hrpconjug
dako
reaction
develop
visual
chemiluminesc
detect
kit
pierc
il
usa
biochip
slide
euroimmun
luebeck
germani
coat
sarscov
infect
vero
cell
use
immunocytochemistri
determin
viru
particl
phage
scfv
specif
antibodi
slide
treat
minut
peroxidas
block
solut
dako
en
vision
system
hrp
wash
tpb
buffer
incub
hour
rt
phage
antibodi
particl
resuspend
tpb
scfv
contain
supernat
control
biochip
slide
incub
irrelev
antiglucos
oxidas
phage
scfv
antibodi
extens
wash
tpb
slide
incub
hour
rt
secondari
mous
antibodi
tpb
amersham
antiflag
secondari
mous
antibodi
tpb
sigmaaldrich
label
phage
scfv
reactiv
antibodi
respect
wash
slide
treat
minut
rt
cromogen
solut
dako
inspect
light
microscop
plasmid
dna
individu
bacteri
coloni
clone
digest
specif
endonucleas
region
sequenc
autom
dna
sequenc
mmedicalgenenco
pomezia
itali
use
ttt
tct
gta
tga
pelbback
cgc
tgg
att
gtt
att
primer
isol
specif
scfv
antibodi
aliquot
human
synthet
librari
contain
approxim
cfu
phage
introduc
pan
maxisorp
immunotub
coat
purifi
sarscov
n
protein
antigen
nonspecif
absorb
phage
remov
wash
bound
phage
elut
amplifi
use
next
cycl
pan
describ
elsewher
use
protocol
phage
antibodi
popul
specif
recogn
n
protein
sarscov
isol
three
round
select
plate
agar
phage
antibodyinfect
cell
allow
growth
individu
phagemid
clone
solubl
scfv
deriv
iptg
induct
coloni
screen
elisa
sever
prove
specif
n
protein
figur
nposit
scfv
clone
analys
elisa
reactiv
protein
fragment
figur
three
distinct
class
scfv
antibodi
recogn
either
intact
n
protein
also
fragment
identifi
scfv
antibodi
recogn
n
protein
none
fragment
instanc
scfv
like
direct
epitop
encompass
two
adjac
protein
fragment
conform
epitop
express
integr
protein
absenc
scfv
antibodi
react
fragment
somewhat
match
lower
antigen
polypeptid
compar
immunodomin
fragment
despit
report
reactiv
sever
linear
synthet
epitop
region
sar
sera
howev
rel
low
number
scfv
clone
test
sound
conclus
aspect
three
reactiv
scfv
antibodi
clone
name
one
repres
differ
class
epitop
recognit
n
protein
domain
assess
verifi
biochem
pattern
reactiv
sarscov
infect
cell
dna
sequenc
encod
gene
western
blot
analysi
figur
show
three
antibodi
react
kda
band
correspond
predict
molecular
mass
intact
n
protein
expect
previou
elisa
indic
scfv
recogn
also
kda
kda
band
respect
correspond
predict
molecular
mass
n
protein
fragment
molecular
analysi
phage
antibodi
show
scfv
antibodi
molecular
weight
kda
integr
gene
encod
cognat
scfv
display
phage
data
show
vh
vl
gene
sequenc
show
singl
scfv
antibodi
clone
possess
uniqu
dna
sequenc
encod
region
figur
uniqu
consist
distinct
epitop
recognit
pattern
three
scfv
note
immunocytochem
investig
show
antibodi
specif
recogn
sarscov
particl
infect
vero
cell
figur
two
antibodi
though
genuin
react
n
protein
fragment
elisa
western
blot
see
prove
use
sarscov
determin
infect
cell
use
librari
tool
gener
monoclon
antibodi
viral
pathogen
includ
sarscov
test
show
phage
antibodi
may
recogn
viral
protein
use
antigen
particular
rodent
librari
prove
effect
isol
murin
scfv
exhibit
high
specif
sarscov
e
protein
recogn
kda
protein
western
blot
studi
interestingli
one
clone
isol
select
rodent
librari
kda
e
protein
crossreact
elisa
welldefin
fragment
kda
n
protein
recent
human
mab
identifi
biopan
synthet
librari
sarscov
lysat
isol
scfv
express
phage
prove
recogn
n
protein
elisa
evid
n
protein
recognit
western
blot
studi
sar
infect
cell
shown
effici
display
recombin
antibodi
filament
phage
also
assess
find
show
solubl
human
scfv
select
librari
may
yield
agent
capabl
specif
recogn
sarscov
particl
infect
vero
cell
well
intact
kda
sarscov
n
protein
kda
kda
fragment
western
blot
elisa
investig
figur
knowledg
human
scfv
direct
n
protein
us
isol
character
first
antibodi
far
describ
abl
detect
sarscov
n
protein
differ
routinari
laboratori
techniqu
elisa
western
blot
immunocytochemistri
henc
human
mab
repres
excel
candid
futur
develop
serolog
diagnosi
sarscov
infect
sinc
high
function
clone
express
solubl
antibodi
bacteria
specif
clone
recogn
kda
n
protein
qualiti
clone
give
good
signal
elisa
western
blot
well
stain
sarscov
infect
cell
furthermor
gene
encod
select
antibodi
isol
sequenc
thu
facilit
variou
molecular
approach
includ
site
direct
mutagenesi
matur
bind
affin
construct
whole
recombin
immunoglobulin
sarscov
studi
applic
latter
regard
anoth
immedi
use
human
scfv
direct
n
protein
intracellular
express
novel
strategi
gene
therapi
aim
knockout
replic
cycl
sarscov
infect
cell
thought
intracellular
express
scfv
antibodi
may
superior
altern
method
gene
inactiv
antisens
rna
domin
neg
mutant
high
specif
nevertheless
phage
display
approach
make
feasibl
sever
strategi
isol
neutral
human
mab
provid
immedi
treatment
emerg
prophylaxi
sarscov
vaccin
new
drug
underway
exampl
immun
librari
may
construct
screen
sarscov
protein
use
bcell
convalesc
sar
patient
genet
sourc
specif
vh
vl
altern
synthet
peptid
mimick
immunodomin
epitop
sarscov
protein
may
use
substrat
antigen
identif
specif
scfv
synthet
human
phage
antibodi
librari
sar
sever
acut
respiratori
syndrom
cov
coronaviru
n
nucleocapsid
scfv
singl
chain
fragment
variabl
synthet
scfv
antibodi
phage
librari
cdr
complementar
determin
region
mab
monoclon
antibodi
author
declar
compet
interest
mf
carri
phage
antibodi
scfv
select
differ
nantigen
particip
genet
molecular
biochem
immunohistochem
character
scfv
specif
distinct
epitop
n
protein
pdb
fg
carri
isol
express
product
purif
nucleocapsid
protein
sarscov
aa
particip
phage
antibodi
select
carri
immunoassay
biochem
character
scfv
n
protein
polypeptid
fragment
acr
firstli
ideat
develop
genet
molecular
model
isol
identifi
express
sarscov
n
protein
fragment
ac
promot
genet
molecular
studi
sarscov
n
protein
particip
design
studi
supervis
experi
critic
revis
manuscript
mc
conceiv
studi
promot
approach
phage
librari
select
specif
scfv
human
antibodi
sarscov
protein
furthermor
mc
particip
design
coordin
research
draft
manuscript
author
read
approv
final
version
manuscript
prepubl
histori
paper
access
